RhumbLine Advisers’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $309K | Buy |
38,091
+13,361
| +54% | +$108K | ﹤0.01% | 2967 |
|
2025
Q1 | $174K | Sell |
24,730
-30,993
| -56% | -$218K | ﹤0.01% | 3177 |
|
2024
Q4 | $414K | Buy |
55,723
+31,056
| +126% | +$231K | ﹤0.01% | 2786 |
|
2024
Q3 | $122K | Sell |
24,667
-2,232
| -8% | -$11K | ﹤0.01% | 3445 |
|
2024
Q2 | $138K | Buy |
26,899
+25,378
| +1,669% | +$130K | ﹤0.01% | 3401 |
|
2024
Q1 | $8.08K | Hold |
1,521
| – | – | ﹤0.01% | 3905 |
|
2023
Q4 | $9.41K | Hold |
1,521
| – | – | ﹤0.01% | 3872 |
|
2023
Q3 | $11.5K | Sell |
1,521
-1,637
| -52% | -$12.4K | ﹤0.01% | 3856 |
|
2023
Q2 | $30.5K | Sell |
3,158
-38,804
| -92% | -$375K | ﹤0.01% | 3751 |
|
2023
Q1 | $158K | Buy |
41,962
+647
| +2% | +$2.44K | ﹤0.01% | 2788 |
|
2022
Q4 | $268K | Buy |
41,315
+614
| +2% | +$3.98K | ﹤0.01% | 2713 |
|
2022
Q3 | $362K | Buy |
40,701
+2,820
| +7% | +$25.1K | ﹤0.01% | 2643 |
|
2022
Q2 | $378K | Buy |
37,881
+1,471
| +4% | +$14.7K | ﹤0.01% | 2632 |
|
2022
Q1 | $422K | Sell |
36,410
-3,120
| -8% | -$36.2K | ﹤0.01% | 2495 |
|
2021
Q4 | $439K | Sell |
39,530
-59
| -0.1% | -$655 | ﹤0.01% | 2566 |
|
2021
Q3 | $365K | Buy |
39,589
+756
| +2% | +$6.97K | ﹤0.01% | 2686 |
|
2021
Q2 | $437K | Sell |
38,833
-7,056
| -15% | -$79.4K | ﹤0.01% | 2624 |
|
2021
Q1 | $486K | Sell |
45,889
-100
| -0.2% | -$1.06K | ﹤0.01% | 2512 |
|
2020
Q4 | $499K | Buy |
45,989
+5,437
| +13% | +$59K | ﹤0.01% | 2442 |
|
2020
Q3 | $394K | Sell |
40,552
-6,152
| -13% | -$59.8K | ﹤0.01% | 2398 |
|
2020
Q2 | $372K | Buy |
46,704
+3,576
| +8% | +$28.5K | ﹤0.01% | 2464 |
|
2020
Q1 | $375K | Buy |
43,128
+1,643
| +4% | +$14.3K | ﹤0.01% | 2293 |
|
2019
Q4 | $469K | Buy |
41,485
+82
| +0.2% | +$927 | ﹤0.01% | 2390 |
|
2019
Q3 | $450K | Buy |
41,403
+3,146
| +8% | +$34.2K | ﹤0.01% | 2375 |
|
2019
Q2 | $358K | Sell |
38,257
-1,050
| -3% | -$9.83K | ﹤0.01% | 2513 |
|
2019
Q1 | $483K | Buy |
39,307
+884
| +2% | +$10.9K | ﹤0.01% | 2341 |
|
2018
Q4 | $455K | Buy |
38,423
+11,792
| +44% | +$140K | ﹤0.01% | 2338 |
|
2018
Q3 | $383K | Hold |
26,631
| – | – | ﹤0.01% | 2386 |
|
2018
Q2 | $397K | Buy |
26,631
+1,035
| +4% | +$15.4K | ﹤0.01% | 2407 |
|
2018
Q1 | $334K | Sell |
25,596
-1,225
| -5% | -$16K | ﹤0.01% | 2387 |
|
2017
Q4 | $338K | Sell |
26,821
-4,801
| -15% | -$60.5K | ﹤0.01% | 2404 |
|
2017
Q3 | $410K | Buy |
31,622
+245
| +0.8% | +$3.18K | ﹤0.01% | 2409 |
|
2017
Q2 | $466K | Sell |
31,377
-7,238
| -19% | -$107K | ﹤0.01% | 2342 |
|
2017
Q1 | $463K | Buy |
38,615
+5,660
| +17% | +$67.9K | ﹤0.01% | 2283 |
|
2016
Q4 | $455K | Sell |
32,955
-3,217
| -9% | -$44.4K | ﹤0.01% | 2278 |
|
2016
Q3 | $485K | Buy |
36,172
+240
| +0.7% | +$3.22K | ﹤0.01% | 2225 |
|
2016
Q2 | $387K | Sell |
35,932
-5,993
| -14% | -$64.5K | ﹤0.01% | 2371 |
|
2016
Q1 | $440K | Buy |
41,925
+3,300
| +9% | +$34.6K | ﹤0.01% | 2301 |
|
2015
Q4 | $457K | Buy |
38,625
+2,755
| +8% | +$32.6K | ﹤0.01% | 2300 |
|
2015
Q3 | $419K | Buy |
35,870
+1,793
| +5% | +$20.9K | ﹤0.01% | 2349 |
|
2015
Q2 | $492K | Sell |
34,077
-4,525
| -12% | -$65.3K | ﹤0.01% | 2342 |
|
2015
Q1 | $538K | Buy |
38,602
+2,000
| +5% | +$27.9K | ﹤0.01% | 2263 |
|
2014
Q4 | $505K | Buy |
36,602
+3,200
| +10% | +$44.2K | ﹤0.01% | 2269 |
|
2014
Q3 | $409K | Hold |
33,402
| – | – | ﹤0.01% | 2338 |
|
2014
Q2 | $417K | Buy |
33,402
+9,575
| +40% | +$120K | ﹤0.01% | 2390 |
|
2014
Q1 | $266K | Sell |
23,827
-1,170
| -5% | -$13.1K | ﹤0.01% | 2607 |
|
2013
Q4 | $303K | Hold |
24,997
| – | – | ﹤0.01% | 2585 |
|
2013
Q3 | $305K | Buy |
24,997
+39
| +0.2% | +$476 | ﹤0.01% | 2513 |
|
2013
Q2 | $330K | Buy |
+24,958
| New | +$330K | ﹤0.01% | 2575 |
|